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Is BSE a Threat to Human Health?
During 1996, an
invariably fatal
degenerative brain dis-
ease appeared among
several young people in
Great Britain. Although
its causative agent has
not yet been identified
irrefutably, it was feared
that the victims had
been eating or handling
beef products contami-
nated in some way, and
that the humans con-
tracted the disease from
the beef. Later that year,
in what some might
describe as a panic-
inspired move, the
British government
ordered the slaughter
and incineration of
more than 37,000 head
ofcatde. Almost imme-
diately thereafter, other
European countries
banned the import of
British beef, dealing
that country's beef
industry a staggering
economic blow. The
United States had already banned beef by-products; the ban took effect 1 January
from Great Britain in 1989. 1998. About 80% ofsuch medicines con-
To add to this economic woe, in July tain tallow or gelatinous material made
1997, the European Union banned orally from animal sources, largely from cattle.
ingestible medicines that contain animal According to an FDA spokesperson, this
ban could lead to severe
m ~ shortages of orally
ingestible medicines
worldwide. Citing such
potential shortages and
the continuing need for
these medicines, FDA
ofci ls are trying to put
pressure on the Euro-
pean Union to hold
back on the ban, at least
until drug manufactur-
ers can find substitutes
for the animal by-prod-
ucts. The FDA estimates
that this will take at least
8-12 months, plus time
to make new pills and
win FDA approval for
the manufacturing
change. For the U.S.
pharmaceutical industry
alone, $4 billion in
annual exports is at
stake.
One reason for
these actions is that
many bovines in Great
Britain were stricken
with bovine spongi-
form encephalopathy
(BSE), or mad cow disease. In this sick-
ness, the disease agent eats spongy holes
in bovine brains, making bulls and cows
behave strangely and eventually killing
the animals.
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The most compelling reason, however,
likely was the appearance among humans
of a new variant of the rare but dreaded
Creutzfeldt-Jakob disease (CJD), a human
spongiform encephalopathy believed to
have been transmitted to the patients from
contaminated beefproducts (however, the
means or route of infection is still not
known). Worse, this variant, known as
vCJD or nvCJD, tends to afflict relatively
younger people, even adolescents; normal-
ly, CJD very rarely strikes anyone under
the age of 45. Moreover, the incubation
period of vCJD appears to be only a few
years, compared with the several decades
believed to be required for normal sporadic
or familial CJD. Researchers in this field
note, however, that the incubation time
and pathological manifestation of the dis-
ease is influenced by factors such as the
route of inoculation, the dose and source
of the infecting agent, and the genetics of
the host being infected.
Whether normal or variant, CJD is a
rare, yet horrible, disease that normally
strikes 1-2 persons per million and is
always fatal, generally within one year. Its
outward symptoms in humans resemble
those of Alzheimer's disease in several
ways: depression sets in, dementia begins
and then accelerates, and eventually the
patient loses all physical control of his or
her functions. However, necropsies of
brains of Alzheimer's and CJD patients
show a significant difference: brains of
Alzheimer's patients are laced with amy-
loid plaque, whereas those of CJD
patients, while also containing amyloid
plaque deposits, are found to be full of
spongy holes, principally in the cerebral
tissue. Because ofthese spongy holes, CJD
and its equivalent in animals is also called
spongiform encephalopathy (SE).
As ofDecember 1997, at least 25 peo-
ple in the United Kingdom and France
have contracted vCJD, including 21 cases
reported in the 2 October 1997 issue of
Nature. Each ofthese victims is thought to
have eaten or worked with contaminated
beef or beef products. Results of recent
research indicate compellingly that vCJD
and certain types of SE are transmissible
among animal species, hence the name
transmissible spongiform encephalopathy
(TSE). Moreover, TSE, believed to have
been transmitted via ingestion of cattle
remains, has appeared in domestic and zoo
felines. Using infected tissue from cattle
and from necropsies of vCJD patients,
researchers have induced TSE in mice and
macaque monkeys. However, the only SE
known to be transmitted from animals to
humans has been BSE, and the means of
transmission remains unknown. It should
be emphasized that, while many
researchers maintain that no transmissible
disease agent has so far been identified
irrefutably, there are strong indications of
SE transmissibility.
Did BSE Begin in the Feedlot?
BSE began to show up in cows several years
after cattle feed manufacturers, mainly in
Great Britain, changed the way in which
waste remains from sheep slaughter, consist-
ing partially of brain and nervous tissue,
eyes, spleen, stomach, and other organs,
were prepared for cattle feed. In the late
1970s, the hydrocarbon-solvent extraction
method used in the renderingofoffal began
to be abandoned, resulting in meat and
bone mealwith a much higher fat content.
In the 16 September 1997 issue of
Proceedings ofthe National Academy of
Sciences, Stanley B. Prusiner, a professor of
neurology at the University ofCalifornia at
San Francisco, and colleagues suggested that
this change in the rendering process had
allowed the SE-causing agent fromsheep to
survive rendering and to be passed to cattle
by apath still not clearlyunderstood.
BSE was reported in the United
Kingdom in the early 1980s and by 1987,
there were 446 cases. The practice offeed-
ing the remains of sheep and other rumi-
nant animals to cattle was banned in 1989;
however, the number of cases of BSE
reported increased steadily until 1992,
when it peaked at 36,682 cases. Since
then, the number ofreported cases ofBSE
in the United Kingdom decreased to 8,150
in 1996, and 2,858 through 31 October
1997. It is estimated that a total of 1 mil-
lion cattle were affected by BSE, assuming
an incubation period offive years. Prusiner
and his colleagues consider this figure an
underestimate, given that many cattle,
afflicted or not, normally were slaughtered
at the age of2-3 years. Nevertheless, dur-
ing the past decade, at least 160,000 head
of cattle have died of BSE. Human CJD,
incidentally, was designated by British
authorities as a reportable disease in 1989.
Currently, it appears that the trend of
new cases of BSE in the United Kingdom
and in several other countries where BSE
has appeared (though in the dozens of
cases, at most, unlike the thousands report-
ed in the United Kingdom) is declining.
Preliminary results released by the United
Kingdom Ministry of Agriculture,
Fisheries and Food, however, suggest that
BSE can be passed from a cow to her calf,
which might conceivably lengthen the
time needed until BSE is eradicated.
Nevertheless, maternal transmission rates
were put at about 10%; further evidence
suggests that only cows in the last six
months of infection pass BSE on to their
calves. But the study did not make clear
whether maternal transmission occurred in
utero, at birth, or soon after birth, accord-
ing to the United Kingdom's Spongiform
Encephalopathy Advisory Committee.
Moreover, no infectivity had been reported
in infected cows' placentas, blood, or milk
as ofAugust 1996.
How did BSE come to affect cattle in
the first place? Science has long known
about ovine spongiform encephalopathy,
or OSE (shepherds call the disease
"scrapie," because in addition to becoming
listless and behaving strangely, as do BSE-
affected cattle, sheep scrape themselves
almost incessantly against poles, stakes,
fences, trees, or rocks until they lose much
of their fleece and even sizable chunks of
flesh). Thus one might wonder why, dur-
ing the late 1970s, no one reminded the
scientific community and health authori-
ties that sheep farmers had known about
OSE for at least the previous 200 years.
Moreover, according to an article in the 10
August 1996 issue ofLancet, vertical trans-
mission of OSE (mother to offspring) is
generally accepted as being much more
common among sheep than is vertical
transmission ofBSE in cattle.
Since BSE and vCJD appeared,
researchers in the field have been unable to
agree on what the causative agent that
could act on different animal species might
be. In a report drafted on 12 January
1997, the U.S. Centers for Disease
Control and Prevention suggests, "The eti-
ologic agent is thought to be an unconven-
Potholes in the brain. Histological stains show vacuolization of brain tissue in a BSE-infected cow (left)
and a human with CJD (right).
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tional filterable agent. Currently, there is
no test to detect a patient's immunologic
response to the infection and the etiologic
agent has not been identified. The exact
mode of transmission in humans is not
known; however, the disease can be
induced in laboratory animals by percuta-
neous inoculation of infective material
(brain tissue or cerebral spinal fluid from
an infected person). Transmission in iatro-
genic cases has been associated with the use
of contaminated instruments (i.e., neuro-
surgical instruments or stereotactic elec-
troencephalogram or cortical electrodes
used on infected brain tissue, corneal trans-
plants, and dura mater grafts), transplanta-
tion ofbrain tissue, or inoculation ofcont-
aminated human pituitary derived growth
hormone. Person-to-person transmission
via skin contact or via environmental cont-
amination has not been shown."
The CDC's comments notwithstand-
ing, the 1997 Nobel Prize for Medicine
was awarded to Prusiner for having identi-
fied rogue proteins, known as prion pro-
teins (PrP), that have gone awry in the
brain as the proximate cause of SE. That
year's award was unusual in that no other
researcher shared the prize and that the
Karolinska Institute in Stockholm,
Sweden, which awards the Nobel Prize,
gave it for such cutting-edge work.
According to reports in the scientific and
popular press, the prize committee charac-
terized Prusiner's discovery ofprions as the
finding of a new biological principle of
infection.
Nevertheless, several scientists differ
with this finding. For example, Alan
Puzzling prions. Scientists are creating three-dime
images of prions, such as the recombinant Syrian hamsl
protein, to solve the mysteries of BSE and related di
Source: Molecules R Us home page, National Institutes of Health, at http://molbio.inft
bin/pdb. From: James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kanek
Mehihorn 1, Prusiner SB, Cohen FE. Solution structure of a 142-residue recombinant prion p
sponding to the infectious fragment ofthe scrapie isoform. Proc Natl Acad Sci USA94:1008H
Ebringer of the Infection and Immunity
Group in London proposed in the
November 1997 issue of EHP that BSE is
a form of autoimmune disease. I aura
Manuelidis, head of neuropathology at
Yale Medical School in New Haven,
Connecticut, believes a virus will turn out
to be the SE culprit. Frank 0. Bastian,
director of neuropathology at the
University of South Alabama in Mobile,
posits that the cause is a Spiroplasma, a
microorganism that lacks a cell wall.
Robert Rohwer, director ofthe neurovirol-
ogy unit at the Veterans Affairs Medical
Center in Baltimore, Maryland, was quot-
ed in the 12 July 1996 issue of Science as
characterizing the prion hypothesis as the
cold fusion of infectious disease; he called
for a very high level of skepticism and
scrutiny before it's adopted. Many who
differ with the prion theory maintain that
the concept of a protein acting alone as a
cause of infection and replicating without
DNA, RNA, or both is at odds with gener-
ally accepted principles ofbiology.
Doubts about the Smoking Gun
Essentially, the prion hypothesis states that
rod-shaped prion proteins, which exist
throughout human and animal brains,
cause SE when they mutate into fibril form
and begin eating holes among the neurons.
A gene in the brain apparently encodes the
formation of PrPs. Normal prions are
known as PrP' and are harmless (their
function is not yet understood), whereas
the mutated, and presumably SE-causing
variety is designated as PrPSc. According to
one concept, a mutated prion-coding gene
codes for PrPlc generation. Then,
interaction between PrP' and
PrPI' molecules somehow causes
the normal form to change to the
infective form and attack neu-
rons. The newly formed PrPI
then corrupts another PrP'', and
so the chain continues, a sort of
gruesome biochemical analogue
of Gresham's law of economics,
which holds that bad money
chases out good. Another view is
that, once formed, the PrP5 mol-
ecule joins with a PrP' molecule
to form a PrPSc seed; next, infec-
tion by PrPSc begins a fast poly-
merization of these rogue mole-
cules, which might be regarded as
a kind ofself-replication. 3nsional Apparently, PrPSc is an isomeric
se siesn form ofPrPC with altered chemi-
Dnih.gov/cgi cal properties. For example, PrPl'
oK,GrothD, can be destroyed by protease
proteincorre- enzyme, but PrPI, cannot. Those
6(1997) who espouse the prion hypothesis
believe PrPIc to afflict all human and ani-
mal brains with SE, be it sporadic and
familial CJD, vCJD, BSE, or scrapie.
So despite studies in which BSE and
vCJD were shown to be transmitted to
mice and macaque monkeys, researchers
have yet to dispel all doubt that a rogue
PrP is the smoking gun. What would be
needed as a first step toward proof is a syn-
thesis of normal PrP PrP' that can be
rigorously certified as free of nucleic acid.
The next step would be to demonstrate
that the PrP'- can change into the PrPIc
state and infect animals. As of mid-1996,
no one had been able to create a prion,
much less have it transmute and cause
infection.
Some Suggested Alternatives to
Prions
Considering possible causes of SE, some
researchers ask, is the alternative something
other than prions, or is it something that
must be present to cause normal prions to
go awry?
An autoimmune disease. Ebringer and
his colleagues proposed in their EHI' arti-
cle that BSE is caused by cross-reactive
antibodies evoked following exposure of
cows to biological material from cows and
sheep containing bacteria that may cross-
react with bovine self-antigens. He names
an Acinetobacter, an Agrobacterium, and a
Ruminococcus as such bacteria, because ofa
resemblance of some of their protein
sequences to that ofbovine myelin.
Following exposure, damage to nerve
tissue takes place in two stages, according
to Ebringer. First, the outer covering of
neurons the myclin sheath is damaged,
thereby exposing nerve tissue. Then, dam-
age to neurons occurs with relative accu-
mnulation ofself-proteins, such as PrP, that
cannot be readily hydrolyzed. Ebringer says
that injection of infected brain tissue into
experimental animals causes a neurological
immune disorder called experimental aller-
gic encephalomyelitis (EAE), in which the
destruction of myelin brings about vac-
uolization (sponginess) with subsequent
destruction of neuronal tissues. As a cul-
prit, he suggests the molecular mimicry
between bacteria and brain tissue, which
does not conflict with existing tenets of
biology. He proposes testing this hypothe-
sis by examining sera from BSE-afflicted
cattle for antibodies to these bacteria.
An elusive virus. Manuelidis questions
the concept ofrogue prions as the cause of
SE and blames the disease on a virus. A
virus associated with SE has not been
found so far, but Manuelidis observes that
it took hundreds of researchers 10 years to
find the hepatitis C virus. In addition, she
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Through 1987* 1988* 1989 1990 1991 1992 1993 1994 1995 1996 1997**
Great Britain 442 2,469 7,137 14,181 25,032 36,682 34,370 23,944 14,300 8,016 2,788
Northern Ireland 0 4 29 113 170 375 459 345 173 75 20
IsleofMan 0 6 6 22 67 109 111 55 33 11 8
Jersey 0 1 4 8 15 23 35 22 10 12 2
Guernsey 4 34 52 83 75 92 115 69 44 36 40
Total United Kingdom 446 2,514 7,228 14,407 25,359 37,281 35,090 24,435 14,560 8,150 2,858
*Cases of BSE priorto the disease being made notifiable are shown byyear ofreport, apartfrom cases in GreatBritain, which are shown byyear of clinical onsetofdisease.
**Provisional figures: data to 31 October 1997 (necessarily incomplete as calculated by date ofservice of restriction order).
COUNTRY Through 198 198 1999 1991 1992 1993 1994 1995 1996 1997 1998
Belgium 0 0 0 0 0 0 0 0 0 1a -
France 0 0 0 5 0 1 4 3 12 6 18
Ireland (Rep.)b 0 15c 14c 17c 18c 16 19c 16C 73 77
Luxembourg 0 0 0 0 0 0 0 0 0 18a
Netherlands 0 0 0 0 0 0 0 0 0 2a
Portugal 0 0 1d 1d 1d 3d 12 14 29 30 2a
Switzerland 0 0 2 8 15 29 64 68 45 37a
Shown byyear ofconfirmation.
* Data for Belgium: as of31 October 1997;
data for France: as of 12January 1998;
data forLuxembourg: as of 2 December 1997;
last case reported inthe Netherlands: 8April 1997;
last case reported in Portugal: 20January 1998;
data for Switzerland: as of 12 December 1997.
bAll the cases reported by Ireland to the OIE have
been in female animals, apartfrom one imported
5-year-old bull thatwas confirmed positive in 1989.
There have been no cases reported to date in
young male animals (i.e., steers or bulls).
c Includes imported cases: 5 in 1989, 1 in 1990,
2 in 1991 and 1992, 1 in 1994 and 1995.
dImported cases.
reported in 1989 that she separated differ-
ent molecules in infectious brain samples
and found that the most infectious materi-
al did not contain the most PrPSc (other
laboratories have reproduced this finding).
Rather, its density was between that of
protein and a nucleic acid, which one
would expect of a virus, according to
Manuelidis.
Spiroplasma. Bastian rejects the
hypothesis of prions as the cause of TSE.
Instead, he views PrPSc as a disease prod-
uct, rather than a source ofthe infection.
Discovered in 1976, Spiroplasma is an
organism that not only has no cell wall,
but also blends with the cell membranes of
its host. Bastian told the National
Managed Health Care Congress's Second
International Conference on Transmissible
Spongiform Encephalopathies, held in
Washington, DC, in November 1997, that
he has detected genetic material from
Spiroplasma, particularly Spiroplasma
mirum, by polymerase chain reaction
(PCR) in 11 cases of CJD, but not in 10
controls. Direct sequence of the PCR
product shows 98.5% homology with
Spiroplasma DNA, according to Bastian.
He also has shown the Spiroplasma gene in
Reported Cases in Imported Animals
(date of initial detection)
Canada: 1 case (1993)
Denmark: 1 case (1992)
Falkland Islands: 1 case (1989)
Germany:6 cases
(1 in 1992,3 in 1994,2 in 1997)
Italy: 2 cases(1994)
Oman: 2 cases(confirmed in 1989)
scrapie-infected hamster brains. Bastian
presented evidence that the immune sys-
tem is involved in TSE, and that this agent
develops or replicates in a state ofimmune-
tolerance.
In addition, the causative agent is hard
to destroy. It seems to remain virulent after
it is boiled in water or run through a ren-
dering process at the temperatures ofmelt-
ed animal fat. At the TSE conference,
Bastian pointed out that the agent is not
destroyed at pH 2-11; he has shown evi-
dence that Spiroplasma survives this wide
range ofpH shifts. He speculated that sur-
vival through the stomach would be more
characteristic of a living organism than of a
protein, which would tend to be broken
down.
Moreover, as the CDC explains, the
agent is filterable. Bastian notes that
Spiroplasma can go through a 50-nm filter;
by comparison, herpesvirus is about 100
nm in size. This organism's survivability
fits the transmissibility model for TSE,
says Bastian. In addition, he points out
that Spiroplasma replicates in mammalian
Source: The Office Internationale des Epizooties ofthe World Organisation for
Animal Health home page located at http://www.oie.org/HOME.HTM. Tables
are located athttp://www.oie.org/indemne/bse-a.htm.
tissue. Some critics of the autoimmune-
disease and Spiroplasma theories, however,
state that established data and scientific
proofto support them are lacking, and that
PrP, as a self-protein, is never recognized
by the immune system as a homologous
host.
A DiseaseVector?
Could a vector for scrapie and, by exten-
sion, TSE and vCJD, be lurking in grass
and hay that sheep eat? Sometimes,
scrapie-free sheep placed in contact with
infected sheep develop the disease. Also,
scrapie can occur in a previously scrapie-
free flock, and scrapie-free sheep put on
farms where there had been infected
sheep-even though no sheep were there
for up to three years-have developed
scrapie. Does this indicate the presence ofa
reservoir for an infectious agent in the
environment?
Scrapie occurs frequently among sheep
in Iceland. In a letter printed in the 20
April 1996 issue of Lancet, Henryk
Wisniewski, director of the New York
State Institute for Basic Research in
Developmental Disabilities and Mental
Retardation in Staten Island, New York,
and his colleagues there and at the
University of Iceland in Reykjavik
described a study of grass and hay from
farms at which sheep had had scrapie.
First, they removed all such sheep and con-
firmed scrapie by analysis for PrPSc. Then
they collected several species of hay mites
from up to five scrapie-affected Icelandic
farms and froze them at -200C. Mite sam-
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Pill scare. An EU ban on orally ingestible medicines c
mal products could lead to a worldwide shortage of su
ples were thawed, decontaminated, washed
with phosphate-buffered saline (PBS), and
centrifuged. Pellets were then ground and
suspended in PBS. Centrifuged super-
natant was collected for intracerebral injec-
tion into female Compton white mice aged
4-6 weeks. The pellet suspension and cen-
trifugation procedure was repeated and the
supernatant was then injected into mice
intracerebrally orintraperitoneally.
Mites isolated from these Icelandic
farms were shown to contain prion infec-
tivity, as assayed by inoculation into mice.
These prions appear to possess characteris-
tics that distinguish them from other
known strains of scrapie agent, such as
long incubation times, unusual clinical
manifestations ofdisease, and gel profiles
ofprotease-resistant prions.
In their letter to Lancet, Wisniewski
and his colleagues suggest the possibility
that this evidence supports the concept of
an invertebrate reservoir or vector for some
strains ofprions. He points out that exten-
sive precautions to avoid contamination
were taken and that the methods he and
his colleagues used suggest that partially
purified mite preparations contained anti-
genic sites similar to those in PrP.
Wisniewski also suggests that hay mites
acting as a vector or reservoir might have
played a role in the continuing occurrence
of BSE even after British authorities for-
bade the use ofruminant animal products
for cattle feed. Bastian has suggested that
Spiroplasma in the hay mites are the likely
cause ofthis experimental infection.
Testing for theAgent
Researchers in government, academia, and
industry are seeking methods oftesting for
PrPSc orwhatever the disease agent may be.
For example, Mary Jo
Schmerr, a research chemist
at the National Animal
Disease Center in Ames,
Iowa, and her colleagues are
investigating the use of
organic solvent extraction
together with high-perfor-
mance liquid chromatogra-
phy to extract sheep tissues,
including brain, spleen,
lymph nodes, and tonsils.
She told apost-TSE confer-
ence symposium on testing
thatcapillaryelectrophoresis
will be used to characterize
proteins in the extracts and
test for prion protein. In
ontaining ani- addition, an immunoassay
ich drugs. with fluorescent-labeled pep-
tides from prion protein
with laser-induced fluorescence detection
will be conducted to detect the presence of
prion protein.
Also at the symposium, Lily Yang,
chairman and chief executive officer of
Neuromark Corporation in Los Altos,
California, who also was chairperson ofthe
TSE conference, described a rapid ante-
mortem immunoassay, 14,3,3 marker in
cerebrospinal fluid, that has a 99% sensi-
tivity and 98% specificity in CJD patients
with confirmed brain pathology. She
added that a similar study ofBSE-afflicted
cattle from Great Britain showed a similar
high correlation. Yang explained that the
antigen is shared by other animals affected
byTSE, includingsheep and monkeys.
In December 1997, Prusiner, along
with Fred Cohen and Stephen DeArmond,
also of the University ofCalifornia at San
Francisco, announced the development of
a strain of genetically altered mouse that
responds within 250 days to TSE infection
and reliably develops the disease. Most
importantly, the mouse will respond to
lower doses ofinfection.
"This model," says Cohen, a professor
of cellular and molecular pharmacology,
"is sensitive enough that it is now possible
to make an accurate determination of the
amount of BSE prion in brain and other
tissues-muscle, pancreas, liver, and intes-
tine-that are commonly consumed by
humans." This is a particularly critical
achievement because nonbrain tissues,
such as musde, contain lower amounts of
prions. The model will also make possible
more accurate scrutiny ofdrugs and other
medicinal products derived from cattle,
such as collagen for plastic and reconstruc-
tive surgery, and gelatin for food and the
production ofdrug capsules.
Having such a sensitive test also opens
up the door for conducting epidemiologic
studies on the frequency of BSEs in coun-
tries such as the United States and Canada
that are thought to have been spared, says
DeArmond, a professor of pathology and
neurology. And findings in this regard will
determine whether it will be important to
produce transgenic cattle that are resistant
to prions.
Cold Comfortfor NorthAmericans
North Americans may derive some cold
comfort from indications that, to date,
BSE and vCJD have not appeared in
North America. So are North Americans
safe from TSE? One should not say yes
unequivocally. For example, some wild
ruminants in the western United States
and Canada arevulnerable to chronicwast-
ing disease, a scrapie-like affliction.
In addition, SE has been reported in a
variety oflarge and small mammals. While
conducting a study of CJD in south
Florida, Joseph Berger, chairman of the
department ofneurology at the University
of Kentucky in Lexington, observed an
affected patient who was originally a native
of Kentucky and had a history of eating
squirrel brains. Subsequently, five other
patients with confirmed or suspected CJD
with a history of squirrel brain consump-
tion were identified in rural Kentucky, in
collaboration with Eric Waisman. These
case reports, detailed in a letter published
in the 30 August 1997 issue of Lancet,
have suggested the possibility of transmis-
sion of CJD by consumption of brains of
wild animals. Berger cautions that this
observation will require confirmation by
studies of larger populations, and by a
search for a scrapie agent in the brains of
squirrels, which so far have not been
reported as having spongiform
encephalopathies. In the meantime, he
counsels caution in the ingestion of the
brains ofthis arboreal rodent.
Did mad cow disease become a food-
borne human health threat? Absent the
irrefutable identification of a TSE-causing
agent, it's probably prudent to assume that
this has occurred. Perhaps Berger's admo-
nition should be applied to brains and cer-
tain other tissues ofall animals: all unnec-
essary nonfood as well as food contact
should be rigorously avoided, and TSE-
suspect tissue should be disposed of
according to the strictest protocols that
apply to highly infectious waste.
JulianJosephson
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